Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
02 Jul 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2020
|
Download |
|
13 May 2020 |
On business and financial situation |
ROVI releases the presentation related to the first quarter 2020 financial results
|
Download |
|
13 May 2020 |
Interim Management Report |
The company releases the press release related to the 2020 first quarter financial results
|
Download |
|
02 Apr 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the first quarter of 2020
|
Download |
|
02 Apr 2020 |
On business and financial situation |
ROVI informs on the impact of Covid‑19 on the company’s activities
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
04 Apr 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the first quarter of 2019
|
Download |
|
19 Mar 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI Announces Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia
|
Download |
|
26 Feb 2019 |
Informe Anual de Remuneraciones de los Consejeros |
ROVI releases the 2018 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
26 Feb 2019 |
Informe Anual de Gobierno Corporativo |
ROVI releases the 2018 Annual Corporate Governance Report
|
Download |
|
26 Feb 2019 |
Otros sobre gobierno corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
